Immediate Impact
57 standout
Citing Papers
Global, regional, and national burden of thalassemia, 1990–2021: a systematic analysis for the global burden of disease study 2021
2024 Standout
Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis
2024 Standout
Works of Cecile Phan being referenced
Rituximab in refractory myasthenia gravis: a prospective, open‐label study with long‐term follow‐up
2016
Amyotrophic Lateral Sclerosis With Positive Anti-Acetylcholine Receptor Antibodies. Case Report and Review of the Literature
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Cecile Phan | 116 | 37 | 121 | 40 | 20 | 317 | |
| Carmen M. Terzic | 69 | 56 | 84 | 38 | 15 | 339 | |
| Felix E. Chukwudelunzu | 82 | 27 | 80 | 39 | 12 | 336 | |
| Gregory Fishlev | 103 | 37 | 49 | 14 | 13 | 322 | |
| Pasquale Marchione | 72 | 23 | 21 | 44 | 19 | 351 | |
| Kenneth Gaines | 47 | 81 | 55 | 24 | 22 | 357 | |
| Annaluisa Ranieri | 19 | 56 | 38 | 34 | 20 | 289 | |
| Fernando Sierra‐Hidalgo | 135 | 27 | 10 | 23 | 33 | 322 | |
| Justin Kinsella | 102 | 96 | 100 | 8 | 23 | 350 | |
| Praveen Kesav | 100 | 8 | 34 | 34 | 35 | 252 | |
| Husham Sharifi | 81 | 13 | 15 | 16 | 22 | 365 |
All Works
Loading papers...